Trial Details
COMPLETEDBasic Information
| Clinical ID | c1294 |
|---|---|
| Identifier | NCT04613518 |
| Trial Title | A Study of the Safety, Efficacy, and Biomarker Response of BMS-986165 in Participants With Moderate to Severe Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Colitis, Ulcerative |
| Interventions | DRUG: BMS-986165|OTHER: Placebo Comparator |
Participant Information
| Sponsor | Bristol-Myers Squibb |
|---|---|
| City | San Diego |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2021-03-15 |
|---|---|
| Primary Completion Date | 2023-05-31 |
| Completion Date | 2023-11-29 |